MetLife Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,786
| Closed | -$3.39M | – | 2860 |
|
|
2022
Q3 | $3.39M | Sell |
13,786
-183
| -1% | -$45K | 0.03% | 625 |
|
|
2022
Q2 | $3.46M | Sell |
13,969
-258
| -2% | -$63.9K | 0.03% | 645 |
|
|
2022
Q1 | $4.71M | Buy |
14,227
+4,289
| +43% | +$1.42M | 0.03% | 571 |
|
|
2021
Q4 | $3.57M | Sell |
9,938
-165
| -2% | -$59.3K | 0.03% | 581 |
|
|
2021
Q3 | $3.29M | Sell |
10,103
-252
| -2% | -$82K | 0.03% | 585 |
|
|
2021
Q2 | $3.23M | Sell |
10,355
-277
| -3% | -$86.5K | 0.03% | 627 |
|
|
2021
Q1 | $3.39M | Sell |
10,632
-196
| -2% | -$62.5K | 0.03% | 599 |
|
|
2020
Q4 | $3.51M | Sell |
10,828
-445
| -4% | -$144K | 0.03% | 539 |
|
|
2020
Q3 | $3.12M | Sell |
11,273
-386
| -3% | -$107K | 0.03% | 518 |
|
|
2020
Q2 | $2.82M | Buy |
11,659
+20
| +0.2% | +$4.83K | 0.03% | 565 |
|
|
2020
Q1 | $1.69M | Sell |
11,639
-356
| -3% | -$51.7K | 0.02% | 673 |
|
|
2019
Q4 | $2.05M | Sell |
11,995
-354
| -3% | -$60.4K | 0.02% | 804 |
|
|
2019
Q3 | $2.2M | Sell |
12,349
-89
| -0.7% | -$15.8K | 0.02% | 743 |
|
|
2019
Q2 | $3.24M | Sell |
12,438
-376
| -3% | -$97.9K | 0.03% | 573 |
|
|
2019
Q1 | $3.66M | Sell |
12,814
-64
| -0.5% | -$18.3K | 0.04% | 507 |
|
|
2018
Q4 | $4.19M | Sell |
12,878
-174
| -1% | -$56.6K | 0.05% | 355 |
|
|
2018
Q3 | $5.87M | Buy |
13,052
+613
| +5% | +$276K | 0.06% | 301 |
|
|
2018
Q2 | $5.09M | Sell |
12,439
-13,812
| -53% | -$5.65M | 0.06% | 301 |
|
|
2018
Q1 | $7.64M | Sell |
26,251
-326
| -1% | -$94.9K | 0.09% | 204 |
|
|
2017
Q4 | $4.98M | Buy |
+26,577
| New | +$4.98M | 0.06% | 329 |
|